which recently surpassed ovarian cancer as the deadliest gynecologic malignancy. While Buckanovich has studied ovarian cancer ...

Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

This week, Bismarck Region President and CEO Dr. Todd Schaffer said the clinic is adding cardiology outreach services on the ...

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic ...

Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo ® robotic ...

Susan K. Bohnenkamp, an oncology clinical nurse specialist, is recognized for her compassionate and expert care, going above and beyond to support her patients through their cancer journey.

The procedure, called Uterine Transposition, consists on temporarily suspending the uterus in the abdomen so the patient can ...

On Friday, WVU Medicine held a conference at the Morgantown Marriott Waterfront Hotel inviting WVU Medicine surgeons and ...

Urinary incontinence, or loss of bladder control, is a quality of life condition that affects half of all women in midlife. Experts from Penn State Health Obstetrics and Gynecology are hosting a free ...

The Fresh Toast - Million of women suffer every month, now science indicates how cannabis can help with dysmenorrhea.

The research team looked at cell-free DNA fragmentation profiles across the genome combined with measurements of two key biomarkers to detect ovarian cancer.

Ellen Beausang, Chief Commercial Officer of BioReference, shared the excitement, emphasizing how the addition of OvaWatch to the Women's Health portfolio underscores BioReference Health's commitment ...